Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2011.0194
NEWS & VIEWS
|
Sigmoid or rectal cancer: do patients benefit from high ligation of inferior mesenteric artery ?
|
|
Affiliation: Prof. Dr.med. Ernst Hanisch, Chefarzt und Ärztlicher Direktor, Klinik für Allgemein- Viszeral- und Endokrine Chirurgie, Asklepios Klinik Langen, Akademisches Lehrkrankenhaus der JWG-Universität Frankfurt, Röntgenstr 20, 63225 Langen .
Tel: 06103/912 61200; FAX: 06103/9121814,
Email: E.Hanisch@Asklepios.com |
Since there is no abstract available we provide the first paragraph
The extent of lymph node dissection in the surgical treatment of primary left colon or rectal cancer is debated. A latest well designed and appropriately conducted phase 3 randomized trial has provided disappointing results on cetuximab treatment for KRAS wild-type colorectal cancer. Therefore, the interest in achieving the best possible locoregional tumor control by surgery re-attracts major interest by physicians and treatment. In many specialized institutions high ligation of inferior mesenteric artery has been standardized as a surgical procedure with no increase in operating time and postoperative morbidity. But evidence for reducing local and nodal recurrence after this surgical approach is still insufficient. Here, I discuss whether patients with sigmoid or rectal cancer benefit or not from high ligation of inferior mesenteric artery and splenic flexure mobilization.
(Citation: Gastric & Breast Cancer 2011; 10(4) 241-243)
|
|
| You can have an online full-text access and a PDF of this article: |
- Either purchase this paper for €33 EUR. Please, click here
|
|
- Or through one year subscription PayPal
|
|
Online
ISSN : 1109 - 7647
Print ISSN : 1109 - 7655
 We
subscribe to the HONcode principles. Verify
here.
please, read our policy about privacy
and confidentiality of information and transparency
of sponsorship
last
update: 9 September 2011 |
|
